We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Wanbang

News List

Regent Pacific Receives HK$24.96 million After Clinical Trial Approval For FORTACIN(TM) Has Been Obtained prnasia
April 02, 2021
Regent Pacific Group Limited, a specialist healthcare, wellness and life sciences investment group is pleased to announce that the Group has received a payment of US$3.20 million (approximately HK$24.96 million) before deduction of PRC withholding ...
Sirona Biochem Receives $500,000 Milestone from Wanbang contractpharma
August 30, 2018
Sirona Biochem has received a $500,000 milestone payment from partner Wanbang Biopharmaceuticals for approval by the China Food and Drug Administration (CFDA) of the Phase I clinical trial for Sirona's SGLT-2 inhibitor.......